Phenazopyridine-Induced Hemolytic Anemia in G-6-PD Deficiency

@inproceedings{Galun1987PhenazopyridineInducedHA,
  title={Phenazopyridine-Induced Hemolytic Anemia in G-6-PD Deficiency},
  author={Eithan Galun and R. Oren and Michael Glikson and M Friedlander and A Heyman},
  booktitle={Drug intelligence \& clinical pharmacy},
  year={1987}
}
TOTHEEDITOR: Amiodarone therapy is indicated for the treatment of patients with life-threatening cardiac arrhythmias that are refractory to other drugs. Amiodarone is a toxic drug, and the manufacturer recommends that it first be given in the hospital and continued in a monitored environment until control of the arrhythmia occurs. An excellent review article about amiodarone has appeared in the literature.' Since the introduction of amiodarone, it has been implicated in numerous drug… 

Figures from this paper

G-6-PD deficiency
Medications and Glucose-6-Phosphate Dehydrogenase Deficiency
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzyme defect and one of the most common genetic disorders worldwide, with an estimated 400 million people worldwide
A COMPARATIVE STUDY OF PHENAZOPYRIDINE (PYRIDIUM) AND CYSTONE AS SHORT­ TERM ANALGESIC IN UNCOMPLICATED URINARY TRACT INFECTION
It is a   randomized, open label comparative study between   Pyridium and   Cystone    to   asses the analgesic efficacy in  treating burning micturition & pain during voiding of urine   with in 48
Review and drug therapy implications of glucose‐6‐phosphate dehydrogenase deficiency
  • K. Belfield, E. Tichy
  • Medicine, Biology
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • 2018
TLDR
G6PD deficiency should be considered in patients who experience acute hemolysis after exposure to known oxidative medications, infection, or ingestion of fava beans.
Biochemical and Molecular Assessment of Toxicity of Primaquine Metabolites on Erythrocytes
....................................................................................................................... ii DEDICATION
LOCATION OF POINT MUTATIONS IN G 6 PD DEFICIENCY
TLDR
G6PD deficiency still reigns as the most common of all clinically significant enzyme defects, not only in hematology, but in human biology as a whole.
Heinz-Body Hemolytic Anemia Associated with Phenazopyridine and Sulfonamide
TLDR
This case should sensitize the clinician to the development of drug-induced oxidative hemolytic anemia, its clinical features, and its reversibility.

References

SHOWING 1-8 OF 8 REFERENCES
METHEMOGLOBINEMIA AND HEINZ BODY HEMOLYTIC ANEMIA DUE TO PHENAZOPYRIDINE HYDROCHLORIDE.
TLDR
The occurrence of methemoglobinemia and Heinz-body anemia in patients taking phenazopyridine hydrochloride, a urinary-tract analgesic, is recorded and the effects of this drug on human red cells in vitro are described.
Amiodarone: Pharmacology and Antiarrhythmic and Adverse Effects
TLDR
Due to ocular, dermatologic, gastrointestinal, neurologic, cardiovascular, thyroid and pulmonary toxicity, amiodarone should be reserved for use in patients with refractory and/or life‐threatening arrhythmias.
Hetastarch: An Overview of the Colloid and its Metabolism
Hetastarch, ethoxylated amylopectin, has found clinical utility as a plasma volume expansion agent, a sedimenting agent during pheresis, and a pump priming fluid. Hetastarch is a complex mixture of
Albumin/Hetastarch Drug Utilization Review in an Operating Room Pharmacy
TLDR
It was concluded that 93 percent of the patients administered albumin 5% could have received hetastarch 6%.
Interaction of amiodarone and diphenylhydantoin.